PDB Short entry for 4RA4 HEADER TRANSFERASE/TRANSFERASE INHIBITOR 09-SEP-14 4RA4 TITLE CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE C ALPHA IN COMPLEX WITH TITLE 2 COMPOUND 28 ((R)-6-((3S,4S)-1,3-DIMETHYL-PIPERIDIN-4-YL)-7-(2-FLUORO- TITLE 3 PHENYL)-4-METHYL-2,10-DIHYDRO-9-OXA-1,2,4A-TRIAZA-PHENANTHREN-3-ONE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN KINASE C; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 EC: 2.7.11.13; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRKCA; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.A.ARGIRIADI,D.M.GEORGE REVDAT 4 06-MAR-24 4RA4 1 REMARK SEQADV LINK REVDAT 3 22-NOV-17 4RA4 1 REMARK REVDAT 2 04-FEB-15 4RA4 1 JRNL REVDAT 1 08-OCT-14 4RA4 0 JRNL AUTH D.M.GEORGE,E.C.BREINLINGER,M.A.ARGIRIADI,Y.ZHANG,J.WANG, JRNL AUTH 2 P.BANSAL-PAKALA,D.B.DUIGNAN,P.HONORE,Q.LANG,S.MITTELSTADT, JRNL AUTH 3 L.RUNDELL,A.SCHWARTZ,J.SUN,J.J.EDMUNDS JRNL TITL OPTIMIZED PROTEIN KINASE C THETA (PKC THETA ) INHIBITORS JRNL TITL 2 REVEAL ONLY MODEST ANTI-INFLAMMATORY EFFICACY IN A RODENT JRNL TITL 3 MODEL OF ARTHRITIS. JRNL REF J.MED.CHEM. V. 58 333 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25254961 JRNL DOI 10.1021/JM5013006 REMARK 2 REMARK 2 RESOLUTION. 2.63 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.63 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.77 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 11609 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.760 REMARK 3 FREE R VALUE TEST SET COUNT : 553 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.63 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.88 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.56 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2739 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2369 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2608 REMARK 3 BIN R VALUE (WORKING SET) : 0.2313 REMARK 3 BIN FREE R VALUE : 0.3534 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.78 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 131 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2579 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 40 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 72.57 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.65 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01590 REMARK 3 B22 (A**2) : -0.97430 REMARK 3 B33 (A**2) : 0.99010 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.18560 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.334 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.792 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.898 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2679 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3631 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 912 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 69 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 385 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2679 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 327 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3058 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.23 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.65 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.74 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4RA4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-SEP-14. REMARK 100 THE DEPOSITION ID IS D_1000087090. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-NOV-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SI(III) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11659 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.630 REMARK 200 RESOLUTION RANGE LOW (A) : 77.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.61 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.81 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.55700 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25%(W/V) PEG 3350, 0.1M BIS-TRIS, 0.2M REMARK 280 MAGNESIUM CHLORIDE, PH 5.5, VAPOR DIFFUSION, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 56.20600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.23400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 56.20600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.23400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 318 REMARK 465 SER A 319 REMARK 465 PRO A 320 REMARK 465 SER A 321 REMARK 465 GLU A 322 REMARK 465 ASP A 323 REMARK 465 ARG A 324 REMARK 465 LYS A 325 REMARK 465 GLN A 326 REMARK 465 PRO A 327 REMARK 465 SER A 328 REMARK 465 ASN A 329 REMARK 465 ASN A 330 REMARK 465 LEU A 331 REMARK 465 VAL A 618 REMARK 465 SER A 619 REMARK 465 GLY A 620 REMARK 465 LYS A 621 REMARK 465 GLY A 622 REMARK 465 ALA A 623 REMARK 465 GLU A 624 REMARK 465 ASN A 625 REMARK 465 PHE A 626 REMARK 465 ASP A 627 REMARK 465 LYS A 628 REMARK 465 PHE A 629 REMARK 465 PHE A 630 REMARK 465 THR A 631 REMARK 465 ARG A 632 REMARK 465 ILE A 667 REMARK 465 LEU A 668 REMARK 465 GLN A 669 REMARK 465 SER A 670 REMARK 465 ALA A 671 REMARK 465 VAL A 672 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 333 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 347 CG CD CE NZ REMARK 470 LYS A 436 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 405 162.79 172.64 REMARK 500 ARG A 462 11.53 57.66 REMARK 500 ASP A 481 79.44 53.61 REMARK 500 MET A 489 72.01 -101.41 REMARK 500 GLN A 662 46.21 -88.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3KZ A 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4Q9S RELATED DB: PDB REMARK 900 RELATED ID: 4Q9Z RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE CONTAINS AN ILE. NCBI: HTTP://WWW.NCBI.NLM.NIH.GOV/ REMARK 999 PROTEIN/NP_002728.1 DBREF 4RA4 A 318 672 UNP L7RSM7 L7RSM7_HUMAN 318 672 SEQADV 4RA4 ILE A 568 UNP L7RSM7 VAL 568 SEE REMARK 999 SEQADV 4RA4 SER A 619 UNP L7RSM7 CYS 619 ENGINEERED MUTATION SEQRES 1 A 355 ILE SER PRO SER GLU ASP ARG LYS GLN PRO SER ASN ASN SEQRES 2 A 355 LEU ASP ARG VAL LYS LEU THR ASP PHE ASN PHE LEU MET SEQRES 3 A 355 VAL LEU GLY LYS GLY SER PHE GLY LYS VAL MET LEU ALA SEQRES 4 A 355 ASP ARG LYS GLY THR GLU GLU LEU TYR ALA ILE LYS ILE SEQRES 5 A 355 LEU LYS LYS ASP VAL VAL ILE GLN ASP ASP ASP VAL GLU SEQRES 6 A 355 CYS THR MET VAL GLU LYS ARG VAL LEU ALA LEU LEU ASP SEQRES 7 A 355 LYS PRO PRO PHE LEU THR GLN LEU HIS SER CYS PHE GLN SEQRES 8 A 355 THR VAL ASP ARG LEU TYR PHE VAL MET GLU TYR VAL ASN SEQRES 9 A 355 GLY GLY ASP LEU MET TYR HIS ILE GLN GLN VAL GLY LYS SEQRES 10 A 355 PHE LYS GLU PRO GLN ALA VAL PHE TYR ALA ALA GLU ILE SEQRES 11 A 355 SER ILE GLY LEU PHE PHE LEU HIS LYS ARG GLY ILE ILE SEQRES 12 A 355 TYR ARG ASP LEU LYS LEU ASP ASN VAL MET LEU ASP SER SEQRES 13 A 355 GLU GLY HIS ILE LYS ILE ALA ASP PHE GLY MET CYS LYS SEQRES 14 A 355 GLU HIS MET MET ASP GLY VAL THR THR ARG TPO PHE CYS SEQRES 15 A 355 GLY THR PRO ASP TYR ILE ALA PRO GLU ILE ILE ALA TYR SEQRES 16 A 355 GLN PRO TYR GLY LYS SER VAL ASP TRP TRP ALA TYR GLY SEQRES 17 A 355 VAL LEU LEU TYR GLU MET LEU ALA GLY GLN PRO PRO PHE SEQRES 18 A 355 ASP GLY GLU ASP GLU ASP GLU LEU PHE GLN SER ILE MET SEQRES 19 A 355 GLU HIS ASN VAL SER TYR PRO LYS SER LEU SER LYS GLU SEQRES 20 A 355 ALA VAL SER ILE CYS LYS GLY LEU MET THR LYS HIS PRO SEQRES 21 A 355 ALA LYS ARG LEU GLY CYS GLY PRO GLU GLY GLU ARG ASP SEQRES 22 A 355 VAL ARG GLU HIS ALA PHE PHE ARG ARG ILE ASP TRP GLU SEQRES 23 A 355 LYS LEU GLU ASN ARG GLU ILE GLN PRO PRO PHE LYS PRO SEQRES 24 A 355 LYS VAL SER GLY LYS GLY ALA GLU ASN PHE ASP LYS PHE SEQRES 25 A 355 PHE THR ARG GLY GLN PRO VAL LEU TPO PRO PRO ASP GLN SEQRES 26 A 355 LEU VAL ILE ALA ASN ILE ASP GLN SER ASP PHE GLU GLY SEQRES 27 A 355 PHE SEP TYR VAL ASN PRO GLN PHE VAL HIS PRO ILE LEU SEQRES 28 A 355 GLN SER ALA VAL MODRES 4RA4 TPO A 497 THR PHOSPHOTHREONINE MODRES 4RA4 TPO A 638 THR PHOSPHOTHREONINE MODRES 4RA4 SEP A 657 SER PHOSPHOSERINE HET TPO A 497 11 HET TPO A 638 11 HET SEP A 657 10 HET 3KZ A 701 31 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM 3KZ (1R)-9-[(3S,4S)-1,3-DIMETHYLPIPERIDIN-4-YL]-8-(2- HETNAM 2 3KZ FLUOROPHENYL)-1-METHYL-3,5-DIHYDRO[1,2,4]TRIAZINO[3,4- HETNAM 3 3KZ C][1,4]BENZOXAZIN-2(1H)-ONE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 1 SEP C3 H8 N O6 P FORMUL 2 3KZ C24 H27 F N4 O2 FORMUL 3 HOH *40(H2 O) HELIX 1 1 LYS A 335 THR A 337 5 3 HELIX 2 2 LYS A 372 ASP A 378 1 7 HELIX 3 3 ASP A 380 LEU A 393 1 14 HELIX 4 4 ASP A 424 GLY A 433 1 10 HELIX 5 5 LYS A 436 ARG A 457 1 22 HELIX 6 6 LYS A 465 ASP A 467 5 3 HELIX 7 7 THR A 501 ILE A 505 5 5 HELIX 8 8 ALA A 506 ALA A 511 1 6 HELIX 9 9 LYS A 517 GLY A 534 1 18 HELIX 10 10 ASP A 542 HIS A 553 1 12 HELIX 11 11 SER A 562 MET A 573 1 12 HELIX 12 12 HIS A 576 ARG A 580 5 5 HELIX 13 13 GLU A 586 HIS A 594 1 9 HELIX 14 14 ALA A 595 ARG A 598 5 4 HELIX 15 15 ASP A 601 ASN A 607 1 7 HELIX 16 16 ASP A 641 ASN A 647 1 7 HELIX 17 17 ASP A 649 GLU A 654 5 6 SHEET 1 A 6 PHE A 339 LYS A 347 0 SHEET 2 A 6 LYS A 352 ARG A 358 -1 O LEU A 355 N LEU A 342 SHEET 3 A 6 LEU A 364 LYS A 371 -1 O ILE A 367 N MET A 354 SHEET 4 A 6 ARG A 412 MET A 417 -1 O LEU A 413 N LEU A 370 SHEET 5 A 6 LEU A 403 GLN A 408 -1 N SER A 405 O VAL A 416 SHEET 6 A 6 TYR A 658 VAL A 659 -1 O TYR A 658 N CYS A 406 SHEET 1 B 2 VAL A 469 LEU A 471 0 SHEET 2 B 2 ILE A 477 ILE A 479 -1 O LYS A 478 N MET A 470 LINK C ARG A 496 N TPO A 497 1555 1555 1.33 LINK C TPO A 497 N PHE A 498 1555 1555 1.35 LINK C LEU A 637 N TPO A 638 1555 1555 1.35 LINK C TPO A 638 N PRO A 639 1555 1555 1.35 LINK C PHE A 656 N SEP A 657 1555 1555 1.34 LINK C SEP A 657 N TYR A 658 1555 1555 1.33 SITE 1 AC1 11 GLY A 346 PHE A 350 VAL A 353 ALA A 366 SITE 2 AC1 11 THR A 401 MET A 417 GLU A 418 VAL A 420 SITE 3 AC1 11 ASP A 467 ASN A 468 ASP A 481 CRYST1 112.412 44.468 85.502 90.00 114.72 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008896 0.000000 0.004095 0.00000 SCALE2 0.000000 0.022488 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012876 0.00000